Private Advisor Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2K | Buy |
+28,000
| New | +$15.2K | ﹤0.01% | 2384 |
|
|
2022
Q3 | – | Sell |
-12,631
| Closed | -$52K | – | 2097 |
|
|
2022
Q2 | $52K | Buy |
+12,631
| New | +$52K | ﹤0.01% | 2003 |
|
|
2022
Q1 | – | Sell |
-11,766
| Closed | -$89K | – | 2235 |
|
|
2021
Q4 | $89K | Sell |
11,766
-18,284
| -61% | -$138K | ﹤0.01% | 2030 |
|
|
2021
Q3 | $271K | Buy |
30,050
+11,252
| +60% | +$101K | ﹤0.01% | 1747 |
|
|
2021
Q2 | $225K | Sell |
18,798
-123
| -0.7% | -$1.47K | ﹤0.01% | 1771 |
|
|
2021
Q1 | $237K | Sell |
18,921
-3,131
| -14% | -$39.2K | ﹤0.01% | 1657 |
|
|
2020
Q4 | $344K | Buy |
+22,052
| New | +$344K | ﹤0.01% | 1404 |
|
|
2020
Q3 | – | Sell |
-6,200
| Closed | -$56K | – | 3114 |
|
|
2020
Q2 | $56K | Buy |
+6,200
| New | +$56K | ﹤0.01% | 2038 |
|
|
2019
Q1 | – | Sell |
-20,300
| Closed | -$233K | – | 1596 |
|
|
2018
Q4 | $233K | Buy |
20,300
+5,842
| +40% | +$67.1K | 0.01% | 1134 |
|
|
2018
Q3 | $245K | Buy |
+14,458
| New | +$245K | 0.01% | 1333 |
|
|
2014
Q2 | – | Sell |
-23,054
| Closed | -$417K | – | 934 |
|
|
2014
Q1 | $417K | Buy |
+23,054
| New | +$417K | 0.04% | 470 |
|